Length time bias in surveillance for hepatocellular carcinoma and how to avoid it

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma

(2014) Alessandro Cucchetti et al.   JOURNAL OF HEPATOLOGY

Hepatocellular Carcinoma Presenting at Contrast-Enhanced Multi–Detector-Row Computed Tomography or Gadolinium-Enhanced Magnetic Resonance Imaging as a Small (≤2 cm), Indeterminate Nodule

(2012) Alessandro Furlan et al.   JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities

(2011) Jean-Claude Trinchet et al.   HEPATOLOGY

Feasibility of conducting a randomized control trial for liver cancer screening: Is a randomized controlled trial for liver cancer screening feasible or still needed?

(2011) Hossein Poustchi et al.   HEPATOLOGY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

(2010) Masao Omata et al.   Hepatology International

Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival

(2008) S. W. Duffy et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach

(2008) Jonathan D Mahnken et al.   STATISTICAL METHODS IN MEDICAL RESEARCH